危重患者多重耐药鲍曼不动杆菌感染的药学监护分析

Analysis on Pharmaceutical Care for Critical Patients with Multi-drug Resistant Acinetobacter Baumannii Infection

目的:探讨临床药师对多重耐药鲍曼不动杆菌感染的危重患者实施药学监护的特点。方法:回顾性分析36例危重患者感染多重耐药鲍曼不动杆菌的病原菌分布、细菌耐药情况、治疗结果及进行药学监护的情况。结果:多重耐药鲍曼不动杆菌耐药情况严重,危重患者感染后治疗困难。结论:临床药师应深入临床,发挥药学专长,加强药学监护,参与危重患者多重耐药鲍曼不动杆菌感染治疗方案的制订,这对于抗感染药物的合理应用,防止耐药菌株产生是非常重要的。

OBJECTIVE：To investigate the characteristics of pharmaceutical care for critical patients with multi-drug resistant Acinetobacter baumanni infection.METHODS：Retrospective analysis was applied to analyze the distribution of pathogenic bacteria,drug resistance,therapeutic results and pharmaceutical care in 36 critical patients with multi-drug resistant Acinetobacter baumanni infection.RESULTS：Multi-drug resistant Acinetobacter baumannii had severe drug resistance to antibiotics.It is difficult for critical patients to treat Acinetobacter baumannii infection after infection.CONCLUSION：Clinical pharmacist should be engage in clinical practice,give full play to their clinical expertise and enhance pharmaceutical care.It is very important for prevention of multi-drug resistant strains and appropriate use of drugs that clinical pharmacist be involved in formulating therapeutic regimes for multi-drug resistant Acinetobacter baumannii infection and strengthen pharmaceutical care.